Core Insights - Nanyang, located in southern Henan, has a strong foundation for biomass manufacturing and energy conversion, with over 30 million tons of biomass raw materials produced annually, including over 10 million tons of crop straw and over 10 million livestock [1] - The "2025 Nanyang Synthetic Biology Industry Conference" established the "Central Plains Synthetic Biology Industry-Academia-Research Innovation Alliance" and released the "Biomanufacturing Pilot Zone Action Plan" 1.0, aiming to develop a trillion-level synthetic biology industry cluster [1][5] - The synthetic biology industry in Nanyang has a solid demand foundation, with Muyuan, a leading pig farming company, driving the development of synthetic biology technology through cost reduction initiatives [1][3] Company Developments - In 2023, Muyuan partnered with Westlake University to establish the Nanyang Westlake Muyuan Synthetic Biology Research Institute and Muyuan Laboratory, focusing on producing small amino acids through synthetic biology technology [2] - Muyuan's production of synthetic biological products has commenced, with an annual output of 30,000 tons, promoting the industrialization of amino acid biosynthesis technology [2] Financial Performance - Muyuan's 2025 mid-year performance forecast indicates a net profit of 10.2 billion to 10.7 billion yuan, representing a year-on-year increase of 1129.97% to 1190.26% [3] - The company expects a non-net profit of 10.6 billion to 11.1 billion yuan, reflecting a year-on-year growth of 882.95% to 929.31% [3] - The significant increase in performance is attributed to a rise in pig output and a decrease in breeding costs, with the total cost of pig farming dropping from 13.1 yuan/kg at the beginning of the year to below 12.1 yuan/kg by June [3] Industry Trends - The application of synthetic biology technology in the livestock industry is just a small part of its potential, with future applications expected in materials, agricultural technology, food, and healthcare [4] - Nanyang is developing a comprehensive industrial support service system, focusing on energy integration and logistics to further reduce production costs [4][6] - The region aims to focus on key areas such as feed amino acid substitution, biomedicine, and bio-based materials, driving the entire industry chain upgrade through breakthroughs in synthetic biology [6]

以下文章来源于超越 J Curve ，作者超越J曲线 超越 J Curve . 用数据延伸你的阅读 将投中网设为"星标⭐"，第一时间收获最新推送 本期带来2025年2月VC/PE市场报告。春节影响下虽市场活跃度持续放缓，投资同比大幅增加，头部 省市持续活跃。 作者丨投中研究院 来源丨超越 J Curve 核心发现 第一部分 VC/PE市场募资分析 基金数量环比减少35%，募资动能持续趋弱； 嘉兴、深圳、九江三地募资同比增幅大幅赶超行业均值； 投资数量规模同比上涨，头部省市在假期冲击下仍维持较高活跃度； 科技与医疗领衔，政策驱动型资本集聚深化； 资本避险情绪下中小额交易活跃度占优。 募资区域集聚效应凸显，结构性增长点破局 2025年1月，共计24个省市区（含港澳台）新设基金，其中，浙江省新设数量61支位居榜首，江苏省 新设基金47支、广东省及山东省均设立34支紧随其后。同比来看，浙江、江苏、江西等多地基金数 量逆势增加。 VC/PE市场情绪趋冷，募资行为更为审慎 2025年2月，中国VC/PE市场新成立基金数量共计306支，较上月减少168支，环比降幅35%，和去年 同期相比减少69支，同比降幅18%。受宏观经 ...